Market openNon-fractional

Pulse Biosciences/PLSE

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Pulse Biosciences

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.

Ticker

PLSE

Sector

Healthcare

Trading on

NASDAQ

Industry

Health Care Equipment and Supplies

Headquarters

Hayward, United States

Employees

56

PLSE Metrics

BasicAdvanced
$707M
Market cap
-
P/E ratio
-$0.81
EPS
1.73
Beta
-
Dividend rate
$707M
1.73
7.056
6.866
21.484
24.518
-51.83%
-46.73%
-332.14%
17.63
20.13
-16.667
-43.06%
-29.42%

What the Analysts think about PLSE

Analyst Ratings

Majority rating from 2 analysts.
Buy

PLSE Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
0.00% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$0
NaN%
Net income
-$10M
-15.13%
Profit margin
0.00%
NaN%

PLSE Earnings Performance

Earnings per share (EPS)

Company profitability
-
QuarterlyAnnual
Q3 23
Actual
-
Expected
-$0.22
Surprise
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market openNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Pulse Biosciences stock?

Pulse Biosciences (PLSE) has a market cap of $707M as of July 05, 2024.

What is the P/E ratio for Pulse Biosciences stock?

The price to earnings (P/E) ratio for Pulse Biosciences (PLSE) stock is 0 as of July 05, 2024.

Does Pulse Biosciences stock pay dividends?

No, Pulse Biosciences (PLSE) stock does not pay dividends to its shareholders as of July 05, 2024.

When is the next Pulse Biosciences dividend payment date?

Pulse Biosciences (PLSE) stock does not pay dividends to its shareholders.

What is the beta indicator for Pulse Biosciences?

Pulse Biosciences (PLSE) has a beta rating of 1.73. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell Pulse Biosciences stock

Buy or sell Pulse Biosciences stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing